Intrinsic Value of S&P & Nasdaq Contact Us

Rezolute, Inc. RZLT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.86
+120.7%

Stock Statistics — RZLT

Rezolute, Inc. (RZLT) has a market capitalization of $340.78M and trades at $3.56. The 52-week range is 1.07-11.457.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.6, Earnings Per Share (EPS) of $-0.98.

The stock has a beta of 0.66, operates in the Healthcare sector.

Trading Data
Current Price$3.56
52-Week Range1.07-11.457
Volume872.14K
Avg Volume (30D)2.85M
Market Cap$340.78M
Beta (1Y)0.66
Company
IPO Date2013-01-14
Employees64
CEONevan Charles Elam
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS76200L3096
CUSIP76200L309
Income (Latest Year)
EBITDA$-79.86M
Operating Income$-79.89M
Net Income$-74.41M
EPS$-0.98
EPS Diluted$-0.98
Shares Outstanding$76M
Balance Sheet (Latest Year)
Total Assets$175.49M
Current Assets$171.15M
Cash & ST Investments$167.86M
Total Liabilities$13.36M
Total Debt$1.62M
Net Debt$-92.49M
Total Equity$162.13M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-3.6
P/B Ratio2.1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message